Sialadenitis as a complication of radioiodine therapy in patients with thyroid cancer: where do we stand?
CONCLUSION: RAI-induced sialadenitis has a major impact on patients' quality of life. Due to the good prognosis of DTC, the reduction of sialadenitis and its prognosis, prevention, and treatment constitute a priority for the overall treatment of these patients. Further studies that will establish a coherent treatment protocol for this condition are necessary.PMID:34143403 | DOI:10.1007/s42000-021-00304-3
Source: Hormones - Category: Endocrinology Authors: Marios Adramerinas Dimitrios Andreadis Konstantinos Vahtsevanos Athanasios Poulopoulos Kalliopi Pazaitou-Panayiotou Source Type: research
More News: Cancer | Cancer & Oncology | Databases & Libraries | Endocrinology | Hormones | Iodine | Radioiodine Therapy | Stem Cell Therapy | Stem Cells | Study | Thyroid | Thyroid Cancer | Vitamin E | Vitamins | Xerostomia